News from Par Pharmaceutical, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

$codeDebug.log("output array of get country targets countryT

Jul 09, 2014, 08:00 ET Par Pharmaceutical Begins Shipment of Fluphenazine Decanoate Injection, USP $codeDebug.log("output array of get country targets countryT

Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its...


$codeDebug.log("output array of get country targets countryT

Jan 21, 2014, 07:00 ET Par Pharmaceutical to Acquire JHP Pharmaceuticals $codeDebug.log("output array of get country targets countryT

 Par Pharmaceutical Companies, Inc. ("Par") today announced  that it has entered into a definitive agreement to acquire JHP Group...


$codeDebug.log("output array of get country targets countryT

Nov 20, 2013, 09:00 ET Par Pharmaceutical Begins Shipment of Generic Focalin XR® Capsules $codeDebug.log("output array of get country targets countryT

 Par Pharmaceutical Companies, Inc. today announced that it has begun shipping dexmethylphenidate hydrochloride (HCl) 15 mg and 30 mg...


$codeDebug.log("output array of get country targets countryT

May 08, 2013, 12:09 ET Par Pharmaceutical Announces Quarterly Conference Call $codeDebug.log("output array of get country targets countryT

 Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, May 16, 2013, at 10:00 a.m. EDT to review...


$codeDebug.log("output array of get country targets countryT

Oct 25, 2012, 10:01 ET Par Pharmaceutical Receives Final Approval To Market Tretinoin Capsules $codeDebug.log("output array of get country targets countryT

 Par Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Anchen Pharmaceuticals, Inc., has received final approval...


$codeDebug.log("output array of get country targets countryT

Sep 28, 2012, 11:40 ET Par Announces Completion Of Acquisition By TPG $codeDebug.log("output array of get country targets countryT

 Par Pharmaceutical Companies, Inc., and TPG today announced the completion of Par's acquisition by certain affiliates of TPG. "This...


$codeDebug.log("output array of get country targets countryT

Apr 09, 2012, 09:00 ET Par Pharmaceutical Companies to Report First Quarter 2012 Results on May 8, 2012 $codeDebug.log("output array of get country targets countryT

 Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Tuesday, May 8, 2012 at...


$codeDebug.log("output array of get country targets countryT

Apr 06, 2012, 07:30 ET Par Pharmaceutical Begins Shipment of Generic Provigil® $codeDebug.log("output array of get country targets countryT

Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it began shipping all strengths of modafinil tablets, a generic version of...


$codeDebug.log("output array of get country targets countryT

Nov 17, 2011, 12:45 ET Par Pharmaceutical Completes Acquisition of Anchen $codeDebug.log("output array of get country targets countryT

Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has completed its acquisition of Anchen Pharmaceuticals, a privately-held...


$codeDebug.log("output array of get country targets countryT

Oct 14, 2011, 16:15 ET Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES $codeDebug.log("output array of get country targets countryT

Par Pharmaceutical, Inc., the wholly-owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it filed a declaratory...


$codeDebug.log("output array of get country targets countryT

Aug 24, 2011, 07:00 ET Par Pharmaceutical To Acquire Anchen Pharmaceuticals $codeDebug.log("output array of get country targets countryT

Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it entered into a definitive agreement to acquire Anchen Pharmaceuticals, a...


$codeDebug.log("output array of get country targets countryT

May 04, 2010, 07:30 ET Par Pharmaceutical Companies Reports Cash EPS and GAAP EPS of $0.75 for First Quarter 2010 $codeDebug.log("output array of get country targets countryT

Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported results for the first quarter ended March 31, 2010. For the first quarter ended...


$codeDebug.log("output array of get country targets countryT

Feb 05, 2010, 16:45 ET Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film $codeDebug.log("output array of get country targets countryT

Strativa Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the new drug...


$codeDebug.log("output array of get country targets countryT

Apr 01, 2009, 08:00 ET Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical $codeDebug.log("output array of get country targets countryT

First and Only Once-weekly, Self-administered Alternative to Injections for Treatment of Vitamin B12 Deficiency Strativa Pharmaceuticals, the...


$codeDebug.log("output array of get country targets countryT

Feb 25, 2008, 00:00 ET Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine $codeDebug.log("output array of get country targets countryT

WOODCLIFF LAKE, N.J., Feb. 25 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary...


$codeDebug.log("output array of get country targets countryT

Jan 15, 2008, 00:00 ET Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation $codeDebug.log("output array of get country targets countryT

WOODCLIFF LAKE, N.J., Jan. 15 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary...


$codeDebug.log("output array of get country targets countryT

May 04, 2004, 01:00 ET Par Pharmaceutical Begins Shipment of Generic Glucovance(R) Tablets $codeDebug.log("output array of get country targets countryT

SPRING VALLEY, N.Y., May 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc. (NYSE:...


$codeDebug.log("output array of get country targets countryT

Feb 12, 2004, 00:00 ET Par Pharmaceutical to Market Generic Purinethol(R) Tablets $codeDebug.log("output array of get country targets countryT

SPRING VALLEY, N.Y., Feb. 12 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


$codeDebug.log("output array of get country targets countryT

Nov 28, 2003, 00:00 ET Par Pharmaceutical to Begin Shipment of Metformin Hydrochloride Extended-Release Tablets $codeDebug.log("output array of get country targets countryT

SPRING VALLEY, N.Y., Nov. 28 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


$codeDebug.log("output array of get country targets countryT

Nov 06, 2003, 00:00 ET Par Pharmaceutical Announces Joint Development Agreement With Glatt $codeDebug.log("output array of get country targets countryT

SPRING VALLEY, N.Y., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc. (NYSE:...


$codeDebug.log("output array of get country targets countryT

Sep 16, 2003, 01:00 ET Par Pharmaceutical Begins Shipment of Nefazodone Hydrochloride Tablets $codeDebug.log("output array of get country targets countryT

SPRING VALLEY, N.Y., Sept. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


$codeDebug.log("output array of get country targets countryT

Sep 02, 2003, 01:00 ET Par Pharmaceutical Announces Agreement With Bristol-Myers Squibb for Megace(R) $codeDebug.log("output array of get country targets countryT

SPRING VALLEY, N.Y., Sept. 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


$codeDebug.log("output array of get country targets countryT

Jul 07, 2003, 01:00 ET Par Pharmaceutical Announces Licensing Agreement With Paddock Laboratories $codeDebug.log("output array of get country targets countryT

SPRING VALLEY, N.Y., July 7 /PRNewswire-FirstCall/ - Pharmaceutical Resources, Inc. (NYSE: PRX) announced today that through its subsidiary, Par...


$codeDebug.log("output array of get country targets countryT

Oct 21, 2002, 01:00 ET Par Pharmaceutical Announces Filing Of Tramadol Hydrochloride Tablets With Acetaminophen $codeDebug.log("output array of get country targets countryT

SPRING VALLEY, N.Y., Oct. 21 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., a subsidiary of Pharmaceutical Resources, Inc. (NYSE: PRX),...


$codeDebug.log("output array of get country targets countryT

Jan 29, 2002, 00:00 ET Par Pharmaceutical Announces Approvable Status of ANDA For Tramadol HCl Tablets $codeDebug.log("output array of get country targets countryT

SPRING VALLEY, N.Y., Jan. 29 /PRNewswire-FirstCall/ -- Par Pharmaceutical, a subsidiary of Pharmaceutical Resources, Inc. (NYSE: PRX), announced...